Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)

Palifermin, a recombinant human keratinocyte growth factor, was tested for potential benefits on acute graft-versus-host disease (GVHD) and hematopoietic recovery in allogeneic hematopoietic stem cell transplantation (HSCT) recipients. This randomized, double-blind, placebo-controlled, dose-escalati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Blazar, Bruce R., Weisdorf, Daniel J., DeFor, Todd, Goldman, Anne, Braun, Thomas, Silver, Samuel, Ferrara, James L. M.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society of Hematology 2006
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895527/
https://ncbi.nlm.nih.gov/pubmed/16835378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-04-017780
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados